Page last updated: 2024-09-03

olmesartan medoxomil and Dyslipidemia

olmesartan medoxomil has been researched along with Dyslipidemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, Y; Baek, SH; Choi, DH; Hong, TJ; Hyon, MS; Jeong, JO; Kang, WC; Kim, HS; Kim, SH; Kim, YH; Lee, SC; Nam, CW; Park, JS; Park, TH; Seo, HS; Shim, WJ; Shin, JH	1

Trials

1 trial(s) available for olmesartan medoxomil and Dyslipidemia

Article	Year
Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT: Drug design, development and therapy, 2016, Volume: 10 Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Republic of Korea; Rosuvastatin Calcium	2016

Article

Year

Efficacy and safety of fixed-dose combination therapy with olmesartan medoxomil and rosuvastatin in Korean patients with mild to moderate hypertension and dyslipidemia: an 8-week, multicenter, randomized, double-blind, factorial-design study (OLSTA-D RCT:

Drug design, development and therapy, 2016, Volume: 10

Topics: Antihypertensive Agents; Double-Blind Method; Drug Combinations; Dyslipidemias; Female; Humans; Hypertension; Male; Middle Aged; Olmesartan Medoxomil; Republic of Korea; Rosuvastatin Calcium

2016